Log In
person
Mirum Pharmaceuticals Inc
MIRM
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma for Rare and Orphan Diseases |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
178.87M | 95.98% |
| Pharma for Rare and Orphan Diseases |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
7.5M | 4.02% |
| keyboard_arrow_down |
Pharma for Rare and Orphan Diseases
Branded Pharmaceuticals (outsourced)
|
178.87M | 95.98% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma for Rare and Orphan Diseases
Pharmaceutical Patent Licensing
|
7.5M | 4.02% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||